Angiosarcoma of the Head and Neck

 

 Permissions and Reprints

Abstract

Introduction Angiosarcoma of the head and neck is a rare vascular sarcoma associated with high rates of local recurrence and distant metastasis and a poor prognosis.

Objective We describe our experience treating patients with angiosarcoma of the head and neck to evaluate the outcomes, patterns of failure, and current treatments.

Methods We identified six patients with angiosarcoma of the head and neck and treated at our institution between 2000 and 2013. We compared our results to the literature from 1979 to 2013.

Results Mean follow-up was 42 months. Local recurrence rate was 50% with disease-specific survival and 2-year disease-free survival rates of 33.3 and 20%, respectively. Prognostic factors included tumor size > 5 cm and surgical margin status, with no correlation between histologic grade and survival. Combined-modality therapy was only used for aggressive tumors with positive surgical margins but is suggested to improve local control and overall survival.

Conclusions Our data series supports that angiosarcoma of the head and neck has a high rate of recurrence and is associated with a poor prognosis, despite current combined-modality therapy. The study highlights the importance of attaining negative margins during surgical resection, the utility of adjuvant therapies, as well as the need for continued research in developing new management strategies.

• References

• 1 Lydiatt WM, Shaha AR, Shah JP. Angiosarcoma of the head and neck. Am J Surg 1994; 168 (5) 451-454
  CrossrefGoogle Scholar
• 2 Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer 1987; 59 (5) 1046-1057
  CrossrefGoogle Scholar
• 3 Pawlik TM, Paulino AF, McGinn CJ , et al. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer 2003; 98 (8) 1716-1726
  CrossrefGoogle Scholar
• 4 Fury MG, Antonescu CR, Van Zee KJ, Brennan MF, Maki RG. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J 2005; 11 (3) 241-247
  CrossrefGoogle Scholar
• 5 Mark RJ, Tran LM, Sercarz J, Fu YS, Calcaterra TC, Juillard GF. Angiosarcoma of the head and neck. The UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg 1993; 119 (9) 973-978
  CrossrefGoogle Scholar
• 6 De Yao JT, Sun D, Powell AT, Rehmus EH. Scalp angiosarcoma remission with bevacizumab and radiotherapy without surgery: a case report and review of the literature. Sarcoma 2011; 2011: 160369
  Google Scholar
• 7 Ogawa K, Takahashi K, Asato Y , et al. Treatment and prognosis of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients. Br J Radiol 2012; 85 (1019) e1127-e1133
  CrossrefGoogle Scholar
• 8 Ohguri T, Imada H, Nomoto S , et al. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy. Int J Radiat Oncol Biol Phys 2005; 61 (5) 1446-1453
  CrossrefGoogle Scholar
• 9 Sasaki R, Soejima T, Kishi K , et al. Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome. Int J Radiat Oncol Biol Phys 2002; 52 (4) 1032-1040
  CrossrefGoogle Scholar
• 10 Perez MC, Padhya TA, Messina JL , et al. Cutaneous angiosarcoma: a single-institution experience. Ann Surg Oncol 2013; 20 (11) 3391-3397
  CrossrefGoogle Scholar
• 11 Guadagnolo BA, Zagars GK, Araujo D, Ravi V, Shellenberger TD, Sturgis EM. Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp. Head Neck 2011; 33 (5) 661-667
  CrossrefGoogle Scholar
• 12 Hodgkinson DJ, Soule EH, Woods JE. Cutaneous angiosarcoma of the head and neck. Cancer 1979; 44 (3) 1106-1113
  CrossrefGoogle Scholar
• 13 Yang P, Zhu Q, Jiang F. Combination therapy for scalp angiosarcoma using bevacizumab and chemotherapy: a case report and review of literature. Chin J Cancer Res 2013; 25 (3) 358-361
  Google Scholar
• 14 Willers H, Hug EB, Spiro IJ, Efird JT, Rosenberg AE, Wang CC. Adult soft tissue sarcomas of the head and neck treated by radiation and surgery or radiation alone: patterns of failure and prognostic factors. Int J Radiat Oncol Biol Phys 1995; 33 (3) 585-593
  CrossrefGoogle Scholar
• 15 Morrison WH, Byers RM, Garden AS, Evans HL, Ang KK, Peters LJ. Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer 1995; 76 (2) 319-327
  CrossrefGoogle Scholar
• 16 Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 1996; 77 (11) 2400-2406
  CrossrefGoogle Scholar
• 17 Elias AD, Antman KH. Adjuvant chemotherapy for soft tissue sarcoma: an approach in search of an effective regimen. Semin Oncol 1989; 16 (4) 305-311
  Google Scholar
• 18 Nagano T, Yamada Y, Ikeda T, Kanki H, Kamo T, Nishigori C. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer 2007; 110 (3) 648-651
  CrossrefGoogle Scholar
• 19 Isogai R, Kawada A, Aragane Y, Tezuka T. Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel. J Dermatol 2004; 31 (4) 335-341
  CrossrefGoogle Scholar
• 20 Karube R, Sasaki H, Shinozuka K , et al. Angiosarcoma of the scalp diagnosed by the presence of neck inflammation: a case report. Int J Oral Sci 2012; 4 (3) 166-169
  CrossrefGoogle Scholar
• 21 Singla S, Papavasiliou P, Powers B , et al. Challenges in the treatment of angiosarcoma: a single institution experience. Am J Surg 2014; 208 (2) 254-259
  CrossrefGoogle Scholar
• 22 Fuller CK, Charlson JA, Dankle SK, Russell TJ. Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. J Am Acad Dermatol 2010; 63 (4) e83-e84
  CrossrefGoogle Scholar
• 23 Koontz BF, Miles EF, Rubio MA , et al. Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies. Head Neck 2008; 30 (2) 262-266
  CrossrefGoogle Scholar
• 24 Tomita H, Koike Y, Asai M , et al. Angiosarcoma of the scalp successfully treated with pazopanib. J Am Acad Dermatol 2014; 70 (1) e19-e21
  CrossrefGoogle Scholar